Биологическая активность
Pemvidutide is a dual агонист targeting both GLP-1R and GCGR, demonstrating significant efficacy in reducing body weight, liver fat content, and serum липид levels. Its unique mechanism of action makes it a promising candidate for research and therapeutic development in conditions such as non-alcoholic steatohepatitis (NASH) and obesity. This innovative compound offers potential for addressing complex metabolic disorders with a multifaceted approach.
Оригинал на английском
Pemvidutide is a dual agonist targeting both GLP-1R and GCGR, demonstrating significant efficacy in reducing body weight, liver fat content, and serum lipid levels. Its unique mechanism of action makes it a promising candidate for research and therapeutic development in conditions such as non-alcoholic steatohepatitis (NASH) and obesity. This innovative compound offers potential for addressing complex metabolic disorders with a multifaceted approach.
Химические свойства
- CAS №
- 2538014-94-5
- Брутто-формула
- C₁₇₈H₂₇₀N₃₈O₅₃
- Мол. масса
- 3790.27 г/моль
- Синонимы
- GLXC-26955; Pemvidutide; ALT801; 2538014-94-5
3D-структура молекулы
Вращайте мышью · Колесо — масштаб
Хранение и физические свойства
- Условия хранения
- 2 года -20°C порошок, 2 недели 4°C в ДМСО, 6 мес. -80°C в ДМСО
Безопасность и документация
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.